Experience matters. For over 40 years, Glenn Davis’ unwavering commitment to clients has been the delivery of creative and efficient results in dynamic business disputes and cybersecurity challenges. His mission is to provide high-quality, cost-effective, and innovative legal solutions while adhering to the highest ethical standards and professional values. Sound legal judgment and strategic risk management dictate whether trial advocacy or alternative dispute resolution is the best path.
Mr. Davis has applied this approach in a broad range of contexts:
His combination of business and litigation experience helps resolve complex antitrust issues; distribution arrangements; pricing issues; evaluation of mergers and joint ventures, including Hart-Scott-Rodino clearance; monopolization and predatory conduct allegations; responses to Department of Justice Antitrust Division and Federal Trade Commission investigations; intellectual property-antitrust issues; healthcare antitrust; trade association activities; private civil litigation, including class actions; criminal antitrust and related white-collar crime matters, including internal investigations and voluntary disclosure and leniency policies; and corporate compliance programs.
Mr. Davis leads HeplerBroom’s HBCyberGroup, which provides interdisciplinary services to address information security and privacy challenges. Working with leading forensic experts, insurance brokers, and reputation management/PR firms, he offers a range of coordinated services scaled to clients’ individual needs and circumstances.
He regularly represents clients in corporate and securities litigation matters, including closely held corporation shareholder disputes and shareholder class actions involving public companies. In recent years, he has obtained dismissals of several corporate and individual officer and director defendants in three stock drop class actions, including affirmance of two by the Eighth Circuit.
He has broad experience in the area of internal corporate investigations and has conducted several internal investigations for audit committees concerning insider trading, financial reporting and accounting irregularity issues, false claims, Medicare fraud, professional sports performance-enhancing drug usage, and qui tam matters. He completed a recent investigation and voluntary disclosure plan for a Fortune 500 company that resulted in a declination of prosecution in a complicated false claims, scientific fraud, and false testing matter.
Mr. Davis has litigated in administrative tribunals such as hearings and investigative proceedings with the Federal Trade Commission, as well as the Securities Exchange Commission and the Financial Industry Regulatory Authority.
